News | December 14, 2021
Baxter acquires Hillrom for US $ 15 billion
It accelerates the company’s vision for transforming healthcare and advancing patient care worldwide – from the hospital to the home
It accelerates the company’s vision for transforming healthcare and advancing patient care worldwide – from the hospital to the home
The proposed acquisition offers a potentially new, differentiated best-in-class approach to address the unmet need for a broader number of patients with immuno-inflammatory diseases
Oravax's vaccine technology is highly scalable for manufacturing and is easily transferable for wide scale logistical distribution, as there is no need for freezer storage
For the six months ended September 30, 2021, Lyka had reported revenues of Rs 109.87 crore
GlaxoSmithKline Pharmaceuticals Limited has reported consolidated financial results for the period ended September 30, 2021
The Research Services and Biosimilars business segments reported a growth of 17% and 10%, respectively
The revised deal involves a cash consideration only as against the earlier proposal of cash and equity
Transformational partnership establishes PCI as a CDMO and broadens capabilities across drug product lifecycle
Since its inception, the company has either acquired or taken a majority stake in five companies
The aim is to first produce Covid-19 vaccines and then add more vaccines in the years to come
Subscribe To Our Newsletter & Stay Updated
